A Phase 1 clinical trial is evaluating an investigational vaccine designed to protect against coronavirus disease in Seattle.
The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccineon Monday, March 16th.
The study is evaluating different doses of the experimental vaccine for safety, and its ability to induce an immune response in participants. This is the first of multiple steps in the clinical trial process for evaluating the potential benefit of the vaccine.
The investigational vaccine was developed using a genetic platform called mRNA. The investigational vaccine directs the body’s cells to express a virus protein that it is hoped will elicit a robust immune response.
The mRNA-1273 vaccine has shown promising results in animal models, and this is the first tiem it will be used on humans.
Comments
more recommended stories
Tropical Storm Andres is the first storm of the 2021 eastern Pacific hurricane seasonTropical Storm Andres is the first.
Mexico: the deadliest country for journalists in the worldMSN News.- Israel Vázquez, 31, a.
Mexicans march in CDMX for marijuana legalization (VIDEO)Protesters smoked joints and walked from.
Want to rent this house in Tulum?Yuyum Uno Villa, Tulum, Mexico (Vrbo):.
The man who killed Rodolfo with a machete walks free out of prisonOn April 28th, The Yucatan Times.
US schools are open but many students remain hesitant to returnBy Dana Goldstein The New York Times.-.
Renan Barrera proposes public bicycle systemThe PAN candidate presented in Paseo.
Mayor of Ixil hires strippers for Mother’s Day.IXIL Yucatan (Times Media Mexico) –.
Pro-cannabis meeting held at the Parque de la Paz in MéridaThe demonstrators peacefully demanded respect for.
Investors do not want AMLO’s party Morena to have a majority in Congress.72% of investors in the country.
Leave a Comment